UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Racial Differences in the Development of De Novo DSA andTreated AMR Following Heart Transplantation

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S200-S200

2017

Volltextzugriff (PDF)

Increased Risk of Bleeding Associated with VKORC1 Gene Polymorphism in Patients with Continuous Flow Left Ventricular Assist Devices (CF-LVAD)

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S174-S175

2017

Volltextzugriff (PDF)

β-Blockers Use During Support with Continuous-Flow Left Ventricular Assist Device in Patients with and without Right Ventricular Dysfunction

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S171-S171

2017

Volltextzugriff (PDF)

De Novo DQ Donor-Specific Antibodies Are Associated with Worse Outcomes Compared to Non-DQ DSA Following Heart Transplantation

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S42-S42

2016

Volltextzugriff (PDF)

Ultrasound-accelerated, Catheter-directed Thrombolysis in the Treatment of LVAD Thrombosis

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S32-S32

2014

Volltextzugriff (PDF)

Influence of Race/Ethnic Differences in Pre-Transplant Panel Reactive Antibody on Outcomes in Heart Transplant Recipients

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S14-S15

2013

Volltextzugriff (PDF)

Predictors of Out-of-Therapeutic-Range INR during Support with Continuous-Flow Left Ventricular Assist Device

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S84-S85

2016

Volltextzugriff (PDF)

ABO Blood Group and Bleeding Post-LVAD

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S253-S253

2016

Volltextzugriff (PDF)

Race/Ethnic Differences in the Epidemiology of Graft Failure in a Contemporary Cohort

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S90-S90

2014

Volltextzugriff (PDF)

Clinical Scores and Echocardiography for Right Ventricular Failure Risk Prediction after Implantation of Continuous-Flow Left Ventricular Assist Devices

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S273-S273

2013

Volltextzugriff (PDF)

The Risk of Leukopenia with Universal vs. Preemptive Prophylaxis Strategies in Heart Transplant Recipients at Intermediate Risk for CMV Complications

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S117-S117

2021

Volltextzugriff (PDF)

Universal CMV Prophylaxis Mitigates the Risks of Basiliximab Induction in Heart Transplant Recipients at Intermediate Risk (R+) for Post-Transplant CMV Complications

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S117-S117

2021

Volltextzugriff (PDF)

A Multi-Center Study of CMV Prophylaxis Strategies in Intermediate Risk (R+) Heart Transplant Recipients

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S115-S115

2021

Volltextzugriff (PDF)

Racial Differences in Risk of Acute Rejection after Cardiac Transplantation

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S87-S88

2019

Volltextzugriff (PDF)

Sensitization in LVAD Recipients with and without Transfusions

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S453-S453

2019

Volltextzugriff (PDF)

Efficacy of 3 Months vs. 6 Months of Valganciclovir Prophylaxis for Heart Transplant Recipients at Intermediate Risk (R+) for CMV Complications

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S116-S117

2021

Volltextzugriff (PDF)

(1096) - Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S423-S424

2018

Volltextzugriff (PDF)

Validating Patient Prioritization in the 2018 Revised UNOS Heart Allocation System: A Single Center Experience

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S133-S133

2019

Volltextzugriff (PDF)

(363) - Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific Antibodies

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S150-S151

2018

Volltextzugriff (PDF)

(908) - Preemptive vs. Upfront CMV Prophylaxis Strategies and the Risk of Treated CMV in Intermediate Risk Heart Transplant Recipients

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S355-S356

2018

Volltextzugriff (PDF)

(429) - Preemptive vs. Upfront CMV Prophylaxis Strategies and Risk of Non-CMV Herpesvirus Infections in Intermediate Risk Heart Transplant Recipients

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S178-S178

2018

Volltextzugriff (PDF)

Effects of Induction on the Risk of Post-Transplant De Novo DSA

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S387-S388

2019

Volltextzugriff (PDF)

Risk of dnDSA with Various MCS Devices as Bridge-to-Transplant

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S91-S91

2019

Volltextzugriff (PDF)

Outflow Graft Obstruction Causing Recurrent Heart Failure after Left Ventricular Assist Device Implantation

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S98-S98

2020

Volltextzugriff (PDF)

Fasteners for composite structures

Composites, 1982-01, Vol.13 (3), p.233-240

1982

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Surgery
(10)
Life Sciences & Biomedicine
(8)
Biological And Medical Sciences
(4)
Male
(4)
Physics
(4)
Technology
(4)
Adult
(3)
Animals
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Fungi
(3)
Humans
(3)
Physical Sciences
(3)
Toxicology
(3)
Animal Models
(2)
Astrophysical S-Factors
(2)
Basic Biological Sciences
(2)
Body
(2)
Female
(2)
General & Internal Medicine
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Racial Differences in the Development of De Novo DSA andTreated AMR Following Heart Transplantation

Increased Risk of Bleeding Associated with VKORC1 Gene Polymorphism in Patients with Continuous Flow Left Ventricular Assist Devices (CF-LVAD)

β-Blockers Use During Support with Continuous-Flow Left Ventricular Assist Device in Patients with and without Right Ventricular Dysfunction

De Novo DQ Donor-Specific Antibodies Are Associated with Worse Outcomes Compared to Non-DQ DSA Following Heart Transplantation

Ultrasound-accelerated, Catheter-directed Thrombolysis in the Treatment of LVAD Thrombosis

Influence of Race/Ethnic Differences in Pre-Transplant Panel Reactive Antibody on Outcomes in Heart Transplant Recipients

Predictors of Out-of-Therapeutic-Range INR during Support with Continuous-Flow Left Ventricular Assist Device

ABO Blood Group and Bleeding Post-LVAD

Race/Ethnic Differences in the Epidemiology of Graft Failure in a Contemporary Cohort

Clinical Scores and Echocardiography for Right Ventricular Failure Risk Prediction after Implantation of Continuous-Flow Left Ventricular Assist Devices

The Risk of Leukopenia with Universal vs. Preemptive Prophylaxis Strategies in Heart Transplant Recipients at Intermediate Risk for CMV Complications

Universal CMV Prophylaxis Mitigates the Risks of Basiliximab Induction in Heart Transplant Recipients at Intermediate Risk (R+) for Post-Transplant CMV Complications

A Multi-Center Study of CMV Prophylaxis Strategies in Intermediate Risk (R+) Heart Transplant Recipients

Racial Differences in Risk of Acute Rejection after Cardiac Transplantation

Sensitization in LVAD Recipients with and without Transfusions

Efficacy of 3 Months vs. 6 Months of Valganciclovir Prophylaxis for Heart Transplant Recipients at Intermediate Risk (R+) for CMV Complications

(1096) - Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively

Validating Patient Prioritization in the 2018 Revised UNOS Heart Allocation System: A Single Center Experience

(363) - Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific Antibodies

(908) - Preemptive vs. Upfront CMV Prophylaxis Strategies and the Risk of Treated CMV in Intermediate Risk Heart Transplant Recipients

(429) - Preemptive vs. Upfront CMV Prophylaxis Strategies and Risk of Non-CMV Herpesvirus Infections in Intermediate Risk Heart Transplant Recipients

Effects of Induction on the Risk of Post-Transplant De Novo DSA

Risk of dnDSA with Various MCS Devices as Bridge-to-Transplant

Outflow Graft Obstruction Causing Recurrent Heart Failure after Left Ventricular Assist Device Implantation

Fasteners for composite structures

Suchergebnisse filtern